Skip to main content

Articles

Page 13 of 13

  1. In a previous study we demonstrated the existence of numerical and functional alterations of γδ T cells in healthy elderly. Recently, we analysed the involvement of γδ T lymphocytes in malignant melanoma, desc...

    Authors: Francesca Re, Alessia Donnini, Beatrice Bartozzi, Giovanni Bernardini and Mauro Provinciali
    Citation: Immunity & Ageing 2005 2:2
  2. The low-grade inflammation seen with aging is noted particularly in subjects with the metabolic syndrome of aging. Insulin resistance, obesity/abdominal obesity, and risks for many age-related diseases charact...

    Authors: Eric Rudin and Nir Barzilai
    Citation: Immunity & Ageing 2005 2:1
  3. In the recent years, several cytokines have been associated with Alzheimer's disease (AD) development and progression and many studies have correlated this risk with polymorphisms in the genes encoding these m...

    Authors: Lorenza Galimberti, Beatrice Arosio, Carmen Calabresi, Silvia Scurati, Susanna Hamilton, Simona Delli Carpini, Carlo Vergani and Giorgio Annoni
    Citation: Immunity & Ageing 2004 1:6
  4. With advancing age, thymic efficiency shows progressive decline due to thymic involution allowing impaired cell-mediated immunity and the appearance of age-related diseases. The intrinsic cause of thymic invol...

    Authors: Eugenio Mocchegiani, Robertina Giacconi, Catia Cipriano, Elisa Muti, Nazzarena Gasparini and Marco Malavolta
    Citation: Immunity & Ageing 2004 1:5
  5. Atherosclerosis lesions contain abundant immunoglobulins complexed with oxidized LDL (OxLDL) that are endocytosed by macrophages to form foam cells. While recent evidence supports a role for the macrophage sca...

    Authors: David C Calverley, Taya Varteresian, Elizabeth Brass, Denice D Tsao-Wei, Susan Groshen, Wendy J Mack, Thomas A Buchanan, Howard N Hodis and Alan D Schreiber
    Citation: Immunity & Ageing 2004 1:4
  6. Only a small percentage of patients with Alzheimer's disease benefit from current drug therapy and for only a relatively short time. This is not surprising as the goal of these drugs is to enhance existing cer...

    Authors: Marc E Weksler
    Citation: Immunity & Ageing 2004 1:2

Annual Journal Metrics

  • 2022 Citation Impact
    7.9 - 2-year Impact Factor
    6.9 - 5-year Impact Factor
    1.379 - SNIP (Source Normalized Impact per Paper)
    2.387 - SJR (SCImago Journal Rank)

    2023 Speed
    2 days submission to first editorial decision for all manuscripts (Median)
    102 days submission to accept (Median)

    2023 Usage 
    548,376 downloads
    1,115 Altmetric mentions